Nanoscope Therapeutics Licenses Optogenetic CatCh Technology

  • Posted on September 30, 2024
  • By Google News
  • 2 Views
Nanoscope Therapeutics Licenses Optogenetic CatCh Technology

/PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases (IRDs) and...
continue reading...

Author
Google News

You May Also Like